Subjects Experiencing at Least One Solicited Local Adverse Event (8-Day Follow-Up Period after Vaccination, FAS, N = 632).

N = number of subjects in the specified group; n = number of subjects in the specified category (with at least one report of a local adverse event); % = percentages of n based on N; AD = atopic dermatitis; AE = adverse event. FAS = full analysis seta: Injection Site Pain grade 2: pain when moving the limbb: Injection Site Pain grade 3: spontaneously painful. P-value is Fisher’s exact test of the differences in proportions between groups.Subjects Experiencing at Least One Solicited Local Adverse Event (8-Day Follow-Up Period after Vaccination, FAS, N = 632).